Taxotere Hair Loss Lawsuits
Taxotere and Permanent Alopecia (Loss of Hair)
Taxotere (docetaxel) is an injectable chemotherapy drug used in the treatment of breast cancer, non-small cell lung cancer, advanced stomach cancer, head and neck cancer and metastatic prostate cancer. Taxotere chemotherapy treatment is administered every three weeks as opposed to other chemotherapy drugs in its class which need to be given weekly. Less frequent trips to the hospital is an attractive selling point to patients, but because Taxotere is so powerful, it may also damage hair cells and cause hair not to grow back after treatment ends. Doctors and patients in the United States were never warned of the increased risk of permanent alopecia so the option of choosing a drug with less risk of permanent alopecia was never an option. If you or a loved one has experienced permanent hair loss as a result of Taxotere, please call our firm today.
FDA Announces Drug Safety labeling Change for Taxotere
In December 2015, the U.S. Food and Drug Administration (FDA) released a Drug Safety Labeling Announcement regarding Taxotere. The announcement stated that Taxotere’s packaging would include the following language: “Cases of permanent alopecia have been reported.”
AFFECTED BY TAXOTERE?
Are You Eligible for a Taxotere Lawsuit?
The Feeney Law Firm is committed to seeking justice for those affected by Taxotere. Fighting to keep people safe from corporate greed and self-interest is our passion. We are here to help make that process as simple as possible for you and your family. Call us now at 1-800-482-7097 for a FREE consultation. Don’t wait; your time to file a Taxotere lawsuit may be limited.
Do not stop taking these drugs without first speaking to your doctor.